| Active substance |
Levocetirizine |
| Also known as |
Levocetirizine dihydrochloride |
| Blood pressure |
Generally does not affect blood pressure significantly |
| Chemical name |
(R)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid |
| Dosage (medical) |
5 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Relief from allergic symptoms such as sneezing, runny nose, itchy or watery eyes, and hives |
| Formula |
C21H25ClN2O3 |
| Half-life |
6 to 10 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not routinely required |
| Main action |
H1 histamine receptor antagonist |
| Side effects |
Drowsiness, fatigue, dry mouth, headaches |
| Storage conditions |
Store at room temperature, away from excess heat and moisture |
| Strength |
5mg |
| Substance class |
Antihistamine |
| Trade name |
Xyzal |
| Use in sports |
No specific use in sports |
| Water Retention |
Negligible |
| Manufacturer |
Cipla Ltd. |
| Packing |
10 tabs/blister |
